🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Cholangiocarcinoma

Adjuvant Therapy for High-Risk Intrahepatic Cholangiocarcinoma: A Real-World Study NCT07640048n/a1 site📍 Beijing Peking Union Medical College Hospital · Tests: Adebrelimab, Gemcitabine, Cisplatin, S-1, Apatinib Trop2-targeted immunoPET Imaging of Solid Tumors NCT06851663Phase 2, Phase 31 site📍 Shanghai RenJi Hospital · Tests: [68Ga]Ga-NOTA-T4, [68Ga]Ga-NOTA-RT4, [18F]F-RESCA-T4, [18F]F-RESCA-RT4 Phase I/II Trial of Pemigatinib in Combination With Atezolizumab and Bevacizumab for Treatment of Advanced Cholangiocarcinoma With FGFR2 Fusion NCT06439485Phase 1, Phase 21 site📍 Houston M.D. Anderson Cancer Center · Tests: Pemigatinib, Atezolizumab, Bevacizumab Gemcitabine and Oxaliplatin Chemotherapy With or Without a Floxuridine and Dexamethasone Pump in People With Cholangiocarcinoma That Cannot Be Removed With Surgery NCT04891289Phase 211 sites📍 Bethesda📍 St Louis📍 Basking Ridge Memorial Sloan Kettering Cancer Center · Tests: Gemcitabine, Oxaliplatin, Dexamethasone, Floxuridine (FUDR), Implanted Medical Device 68Ga-SorB PET/CT Imaging in Patients With Solid Tumors NCT07760012NA1 site📍 Beijing Peking University Third Hospital · Tests: 68Ga-SorB PET/CT REGULUS: MRI-guided Adaptive SABR for Liver Cancers NCT07223307Phase 21 site📍 Palo Alto Stanford University · Tests: MRI-guided adaptive stereotactic ablative body radiotherapy (SABR) Phase I/II Study: Allogeneic NK-cell Therapy With Chemotherapy for Post-Surgery PDA or Cholangiocarcinoma Patients NCT06730009Phase 1, Phase 21 site📍 Tainan Medigen Biotechnology Corporation · Tests: SLOG + Allogeneic NK cell, SLOG chemotherapy Alternating Chemo-immunotherapy and FGFR Inhibitor for FGFR-positive Biliary or Cholangiocarcinoma NCT07780838Phase 21 site📍 Columbus Ohio State University Comprehensive Cancer Center · Tests: Biospecimen Collection, Cisplatin, Computed Tomography, Durvalumab, Gemcitabine Evaluation of diagnostiC Capacity of eccDNAs as Biomarkers in Indetermined biLiary Stricture(ECCBILE) NCT06277531n/a2 sites📍 Beijing📍 Beijing Peking University Third Hospital A Study of Lirafugratinib in Non-CCA Solid Tumors With FGFR2 Fusion or Rearrangement NCT07359820Phase 219 sites📍 Phoenix📍 Jacksonville📍 Tampa Elevar Therapeutics · Tests: Lirafugratinib A Simple Breath Test to Detect Liver Cancer and Monitor Liver Conditions NCT06864195n/a1 site📍 London Imperial College London Modified Immune Cells (Autologous Dendritic Cells) and a Vaccine (Prevnar) Combined With Immune Checkpoint Inhibition After High-Dose External Beam Radiation Therapy in Treating Patients With Unresectable Liver Cancer NCT03942328Phase 1, Phase 21 site📍 Rochester Mayo Clinic · Tests: Atezolizumab, Bevacizumab, External Beam Radiation Therapy, Pheresis, Pneumococcal 13-valent Conjugate Vaccine Liver Transplantation in Intrahepatic Cholangiocarcinoma NCT06140134n/a2 sites📍 Newark📍 Newark Rutgers, The State University of New Jersey · Tests: Liver Transplant 18F-T2 PET/CT Imaging for CAIX Positive Solid Tumors NCT07557225NA1 site📍 Beijing Peking University First Hospital · Tests: 18F-T2 PET/CT Intra Artherial Therapies in Treatment of Primary Liver Diseases: an Observational Study NCT06774690n/a1 site📍 Bologna IRCCS Azienda Ospedaliero-Universitaria di Bologna Tissue Adhesive Glue Modified Cyanoacrylate (Glubran® 2) in Soft Pancreas NCT07155525NA1 site📍 Minya Minia University · Tests: Pancreaticojejunostomy with Modified N-Butyl-2-Cyanoacrylate (Glubran® 2), Standard(duct-to-mucosa) Pancreaticojejunost… TACE Combined With Immune Checkpoint Inhibitors for Liver Malignant Tumors NCT06487663NA1 site📍 Tianjin Tianjin Medical University Cancer Institute and Hospital · Tests: TACE with ICI Chemotherapy Combined With Adebrelimab and Apatinib as the Perioperative Treatment in Patients With Biliary Tract Cancer NCT06280508Phase 21 site📍 Guangzhou Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · Tests: Adebrelimab, Apatinib, Gemcitabine, cisplatin CT-95 in Advanced Cancers Associated With Mesothelin Expression NCT06756035Phase 19 sites📍 Denver📍 Chicago📍 Grand Rapids Context Therapeutics Inc. · Tests: CT-95 Safety and Efficacy of CD160-Enhanced Autologous Antigen-Specific T-Cells (BTC-Ag-T) in Advanced Biliary Tract Cancer NCT07614061Phase 11 site📍 Shanghai Shanghai Zhongshan Hospital · Tests: BTC-Ag-T (ACH-AgT001), Cyclophosphamide and Fludarabine Novel Subtypes and Treatment Strategies of Patients with Unresectable Combined Hepatocellular Cholangiocarcinoma Based on Multimodal Data NCT06849180n/a1 site📍 Nanjing Zhongda Hospital · Tests: Interventional therapies combined with or without systemic drugs A First in Human Study of PLT012 in Participants With Solid Tumor Cancers NCT07337525Phase 14 sites📍 Los Angeles📍 Dallas📍 Houston Pilatus Biosciences Inc · Tests: PLT012 Precision Medicine in Patients With Unresectable CholAngiocarcinoma: RadioEmbolization and Combined Biological Therapy NCT06375915Phase 24 sites📍 Bergamo📍 Milan📍 Naples Francesco De Cobelli · Tests: radioembolization with Y-90, Durvalumab, Cisplatin, Gemcitabine A Study of PHST001 in Advanced Solid Tumors NCT06840886Phase 120 sites📍 Beverly Hills📍 Los Angeles📍 Palo Alto Pheast Therapeutics · Tests: PHST001, Paclitaxel, Topotecan, Doxorubicin, FOLFIRI Characterization of Biliary Cell-derived Organoids From Bile of PSC and Non-PSC Patients NCT04753996n/a1 site📍 Rochester Mayo Clinic Personalized Tumor Neoantigen mRNA Therapy for Advanced Intrahepatic Cholangiocarcinoma NCT06956716Phase 1, Phase 21 site📍 Hangzhou Zhejiang University · Tests: individualized anti-tumor new antigen iNeo-Vac-R01 injection, Gemcitabine + cisplatin (GP), Sintilimab injection HAIC Combined With Camrelizumab Plus Rivoceranib for Advanced Mixed Hepatocellular-cholangiocarcinoma (HCC-CCA) NCT07105748Phase 21 site📍 Shanghai Fudan University · Tests: Camrelizumab, Rivoceranib (Apatinib), HAIC Obtaining Solid Tumor Tissue From People Having Biopsy or Surgery for Certain Types of Cancer NCT01915225n/a1 site📍 Bethesda National Cancer Institute (NCI) Registry for Advanced Endoscopy NCT05187312n/a1 site📍 Stockholm Region Stockholm · Tests: Endoscopic retrograde Cholangio- pancreatography, Endoscopic ultrasound Endoscopic Radiofrequency Ablation for Unresectable Cholangiocarcinoma NCT06175845NA9 sites📍 Berlin📍 Bonn📍 Chemnitz Universitätsklinikum Hamburg-Eppendorf · Tests: Intraductal biliary radiofrequency ablation
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy